What is Andropause (Late-Onset Hypogonadism)?
Andropause, medically termed as Late-Onset Hypogonadism (LOH), refers to the gradual decline in serum testosterone levels associated with aging in men. Unlike female menopause, which involves a rapid cessation of reproductive capacity, male andropause progresses slowly over years with subtle biological and hormonal shifts. Beginning around the age of 40, free testosterone levels typically decrease by approximately 1% to 2% annually.
Symptoms of Male Andropause
Andropause manifests through a spectrum of physical, emotional, and sexual symptoms. The primary clinical signs resulting from androgen deficiency include:
- Significant reduction in libido and development of erectile dysfunction
- Loss of muscle mass, diminished physical strength, and increase in abdominal fat
- Chronic fatigue, lethargy, reduced energy, and loss of motivation
- Cognitive decline, difficulty concentrating, and impaired short-term memory
- Sleep disturbances, insomnia, and excessive daytime sleepiness
- Mood swings, anxiety, depressive tendencies, and irritability
- Decreased bone mineral density (risk of osteoporosis) and hot flashes
Diagnosis and Laboratory Evaluation
The diagnosis of late-onset hypogonadism cannot be established solely on clinical presentation; objective laboratory confirmation is imperative. Fasting blood samples collected between 08:00 AM and 10:00 AM are analyzed to evaluate total and free testosterone concentrations, accounting for circadian rhythms.
In addition to serum testosterone, the comprehensive diagnostic panel includes:
- SHBG (Sex Hormone-Binding Globulin): Evaluated to calculate bioavailable testosterone.
- LH and FSH: Measured to differentiate primary from secondary hypogonadism.
- Serum Prolactin: Assessed to exclude pituitary hyperprolactinemia.
- PSA (Prostate-Specific Antigen): Required prior to initiating any androgen therapy.
Testosterone Replacement Therapy (TRT) in Adana
For patients with confirmed symptomatic hypogonadism, Testosterone Replacement Therapy (TRT) aims to restore physiological hormone levels. Modern urological practices in Adana utilize individualized treatment algorithms tailored to patient safety profiles and clinical requirements.
Primary Therapeutic Modalities
- Intramuscular Injections: Periodic administration of short- or long-acting testosterone esters.
- Transdermal Gels: Daily topical formulations applied to clean skin for steady systemic absorption.
- Subcutaneous Pellets: Long-acting implants providing continuous hormone release over several months.
Monitoring Protocols and Safety Considerations
Testosterone replacement therapy mandates strict medical surveillance. Patients undergo clinical assessments at 3, 6, and 12 months during the first year of therapy. Essential safety parameters include monitoring hematocrit levels to prevent polycythemia, evaluating liver function, and performing routine serum PSA testing alongside digital rectal examinations. TRT is strictly contraindicated in men with diagnosed or suspected prostate carcinoma or breast cancer.
Lifestyle Modifications and Supportive Care
Optimal management of male hypogonadism incorporates structured lifestyle interventions alongside medical therapy. Regular resistance exercise, adoption of a Mediterranean diet, adequate sleep hygiene, and cessation of tobacco and excessive alcohol consumption contribute significantly to endocrine health and therapeutic outcomes.